Cargando…

Neuropsychiatric Disorders and COVID-19: What We Know So Far

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) affects the central nervous system (CNS), which is shown in a significant number of patients with neurological events. In this study, an updated literature review was carried out regarding neurological disorders in COVID-19. Neurological s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Majolo, Fernanda, da Silva, Guilherme Liberato, Vieira, Lucas, Anli, Cetin, Timmers, Luís Fernando Saraiva Macedo, Laufer, Stefan, Goettert, Márcia Inês
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465079/ https://www.ncbi.nlm.nih.gov/pubmed/34577633 http://dx.doi.org/10.3390/ph14090933

Ejemplares similares

Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19
por: Majolo, Fernanda, et al.
Publicado: (2020)

Neuropsychiatric Consequences of COVID-19: What Do We Know So Far?
por: Machado, Sergio, et al.
Publicado: (2022)

What we know so far
Publicado: (2021)

Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021)

c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer’s Diseases
por: Hepp Rehfeldt, Stephanie Cristine, et al.
Publicado: (2020)

Autoimmune pancreatitis: What we know so far
por: Masood, Muaaz
Publicado: (2021)

Incremental Hemodialysis: What We Know so Far
por: Soi, Vivek, et al.
Publicado: (2022)

Monkeypox transmission—what we know so far
por: Venkatesan, Priya
Publicado: (2022)

Amyloidogenesis: What Do We Know So Far?
por: Alraawi, Zeina, et al.
Publicado: (2022)

Moebius Syndrome: What We Know So Far
por: Zaidi, Syed Muhammad Hussain, et al.
Publicado: (2023)

Heart Rate Variability and Cardiovascular Fitness: What We Know so Far
por: Souza, Hugo Celso Dutra, et al.
Publicado: (2021)

The emotional attentional blink: what we know so far
por: McHugo, Maureen, et al.
Publicado: (2013)

Ketogenic Diet and Epilepsy: What We Know So Far
por: D’Andrea Meira, Isabella, et al.
Publicado: (2019)

Thunderstorm-triggered asthma: what we know so far
por: Harun, Nur-Shirin, et al.
Publicado: (2019)

Diet in the Treatment of Epilepsy: What We Know So Far
por: Verrotti, Alberto, et al.
Publicado: (2020)

Coronavirus advice for associates: what we know so far
por: Goldman, James
Publicado: (2020)

Smoking and COVID-19: What we know so far
por: Shastri, Madhur D., et al.
Publicado: (2021)

COVID-19 and cancer: what we know so far
por: Sidaway, Peter
Publicado: (2020)

Neuroproteomics in Epilepsy: What Do We Know so Far?
por: do Canto, Amanda M., et al.
Publicado: (2021)

Cholangiocarcinoma and liver transplantation: What we know so far?
por: Safarpour, Ali Reza, et al.
Publicado: (2021)

Carotid Artery Calcification: What We Know So Far
por: Ahmed, Madeeha, et al.
Publicado: (2021)

Update on omicron variant: What we know so far
por: Choudhary, Gajendra, et al.
Publicado: (2022)

COVID-19 and Myositis: What We Know So Far
por: Saud, Ahmad, et al.
Publicado: (2021)

Eosinophilic Esophagitis—What Do We Know So Far?
por: Wąsik, Jakub, et al.
Publicado: (2023)

HIV and neoplasms: What do we know so far?
por: de Souza, Thais Faria, et al.
Publicado: (2023)

Fibrocartilaginous dysplasia: What do we know so far?
por: Alshalan, Asma, et al.
Publicado: (2023)

A Special View of What Was Almost Forgotten: p38δ MAPK
por: Anton, Débora Bublitz, et al.
Publicado: (2021)

Neural regeneration research model to be explored: SH-SY5Y human neuroblastoma cells
por: Hoffmann, Lavynia Ferreira, et al.
Publicado: (2022)

The effects of huntingtin-lowering: what do we know so far?
por: Kaemmerer, William F, et al.
Publicado: (2019)

Iron and Virulence in Stenotrophomonas Maltophilia: All We Know So Far
por: Kalidasan, V., et al.
Publicado: (2018)

COVID-19 and the Radiology Department: What We Know So Far
por: Vermani, Sanya, et al.
Publicado: (2020)

Mesoamerican Nephropathy (MeN): What We Know so Far
por: Sanchez Polo, Vicente, et al.
Publicado: (2020)

COVID-19 and Hematology—What Do We Know So Far?
por: Khandait, Harshwardhan, et al.
Publicado: (2020)

The COVID-19 Cytokine Storm; What We Know So Far
por: Ragab, Dina, et al.
Publicado: (2020)

The Role of Contactin 1 in Cancers: What We Know So Far
por: Liang, Yumei, et al.
Publicado: (2020)

Anesthesia Options and the Recurrence of Cancer: What We Know so Far?
por: Cata, Juan P, et al.
Publicado: (2020)

Eosinophil Polymorphonuclear Leukocytes in TB: What We Know so Far
por: Prakash Babu, Senbagavalli, et al.
Publicado: (2019)

COVID-19 and Myocarditis: What Do We Know So Far?
por: Pirzada, Ashar, et al.
Publicado: (2020)

Electronic Cigarettes and Asthma: What Do We Know So Far?
por: Kotoulas, Serafeim-Chrysovalantis, et al.
Publicado: (2021)

COVID-19 and dizziness: What do we know so far?
por: Mezzalira, Raquel
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1cj1i4n5ifqvt6oo3a8jualm5u